Work

Prospective observational pilot study of quantitative light dosimetry in erythropoietic protoporphyria

Year: 2022

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2022.11.036

Authors: Amy K. Dickey, Lina Rebeiz, Haya Raef, Rebecca K. Leaf, Sarina Elmariah, Hetanshi Naik, Karl Anderson, Jared Conley, Christiana Iyasere, Sophia Zhao, Judith S. Birkenfeld, Teresa Arroyo-Gallego, Kristen Wheeden, Sarah Ducamp, David C. Christiani, Mark D. Fleming, Irene Kochevar

Institutions: Harvard University, Massachusetts General Hospital, Icahn School of Medicine at Mount Sinai, The University of Texas Medical Branch at Galveston, Consejo Superior de Investigaciones Científicas, Instituto de Óptica "Daza de Valdés", Massachusetts Institute of Technology, Boston Children's Hospital

Language: English

Topic: Porphyrin Metabolism and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Sanofi, Massachusetts General Hospital, Alnylam Pharmaceuticals, Massachusetts Institute of Technology, Harvard University, Harvard Catalyst, Cleveland Clinic, Cleveland Clinic Foundation, Regeneron Pharmaceuticals, National Comprehensive Cancer Network, Castle Biosciences, Mitsubishi Tanabe Pharma Corporation, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences

Awards: G1717162763, The Harvard Clinical and Translational Science Center, G7453724170, Measuring and Understanding Light Sensitivity in Erythropoietic Protoporphyria

OpenAlex ID: W4310103272

FWCI: 0.572

Cites: 5

Cited by: 8

Related to: 10